We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Cellexus Limited Appoints Discovery Scientific as Distributor in Canada

New distributor appointment is part of an ongoing geographical expansion to drive sales of the Cellexus products.
News

Pathway-Focused Gene Expression Panels Validated for Real-time PCR

Fluidigm and SABiosciences team up to create gene expression panels validated for real-time PCR analysis on the Fluidigm BioMark™ System.
News

Roche NimbleGen Commits to GMP and FDA Submission for Microarrays

Roche NimbleGen announces a company-wide initiative to implement Good Manufacturing Processes for its suite of DNA microarrays.
News

Debiopharm Group™ and Biocartis embark on a Partnership Aiming at Enhancing Personalized Medicine

- Debiopharm Group™ , a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and which has embarked in the field of companion diagnostics with a view to progressing in the area of personalized medicine, today announced the signature of an investment agreement with Biocartis.
News

Molecular Devices Launches New Products & Customer-Focused Brand at Society for Biomolecular Sciences Meeting

New IonWorks Barracuda™ Automated High-Speed Patch Clamp System & AquaMax® 2000/4000 Microplate Washer 96 Cell-Wash Head
News

Chronix Biomedical’s Serum DNA Assays Monitor Disease Activity and Treatment Response in MS

Newly published study supports the ability of Chronix’s serum DNA blood tests to monitor disease activity and response to treatment in multiple sclerosis.
News

Pathways that can Repair BRCA1 Cancer Gene Mutation Clarified in Mice

Scientists compensated for mutations in the Brca1 gene that can lead to cancer by deleting a second gene, lessening the probability of cancer.
News

Rexahn Pharmaceuticals Submits Serdaxin® Phase II Protocol to FDA for Parkinson’s Disease

The Phase II study will assess Serdaxin’s efficacy as a treatment for Parkinson’s disease in approximately 300 subjects.
News

Rosetta Genomics now Processing Fine-Needle Aspirate Cell Block Samples for Lung Cancer Subclassification

Molecular test that helps determine treatment can now be performed before the tumor is surgically resected.
News

How science could spark a second Green Revolution

'To fight poverty and overpopulation, crops need coaxing. Advances in deep-root food plants may trigger a new Green Revolution.'
Advertisement